Project MURRAY: Feasibility Study
Research type
Research Study
Full title
A randomised controlled trial to study the effectiveness of sMoking cessation in the sURgical pathway befoRe mAjor lung sugerY. Project MURRAY: Feasibility Study
IRAS ID
246910
Contact name
Babu Naidu
Contact email
Sponsor organisation
University of Birmingham
Duration of Study in the UK
1 years, 1 months, 3 days
Research summary
In the UK over 23,000 patients a year undergo major lung surgery. Postoperative lung complications such as pneumonia and respiratory distress are common after major lung surgery, and lead to an increased risk of death, longer hospital stay and re-admissions. The main risk factor for developing these complications is smoking. However currently 1 in 4 patients continue to smoke up until the date of surgery under the current provision of community base NHS smoking cessation services.
The overall aim of this research is to determine if personalised, intense smoking cessation intervention integrated into the surgical pathway improves smoking cessation rates (INT) patients undergoing major elective thoracic surgery when compared to usual care of standard community/hospital based NHS smoking cessation (UC). To answer this research question with substantial evidence of the clinical and cost-effectiveness of INT approach, a multi-centre RCT is required.
Feasibility studies are often a pre-requisite to assess feasibility of a large and expensive full-scale study. We have therefore designed this multicentre feasibility study comparing the effectiveness of INT verses UC in improving smoking cessation rates.
REC name
West Midlands - Black Country Research Ethics Committee
REC reference
19/WM/0097
Date of REC Opinion
4 Jun 2019
REC opinion
Further Information Favourable Opinion